Fluorescence in situ hybridization mapping of esophagectomy specimens from patients with Barrett's esophagus with high-grade dysplasia or adenocarcinoma

Human Pathology

Volumn 43, Issue 2, 2012, Pages 172-179

  Brankley, Shannon M ^a   Fritcher, Emily G Barr ^a   Smyrk, Thomas C ^a   Keeney, Matthew E ^a   Campion, Michael B ^a   Voss, Jesse S ^a   Clayton, Amy C ^a   Wang, Kenneth K ^a   Lutzke, Lori S ^a   Kipp, Benjamin R ^a   Halling, Kevin C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Dysplasia; Esophageal cancer; FISH; Histopathology; Intestinal metaplasia

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER GROWTH; CHROMOSOMAL INSTABILITY; CHROMOSOME 17Q; CHROMOSOME 20Q; CHROMOSOME 8Q; CHROMOSOME 9P; CHROMOSOME ANALYSIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSPLASIA; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS RESECTION; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE METAPLASIA; MALE; SQUAMOUS EPITHELIUM; STOMACH EPITHELIUM; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; ADULT; AGED; BARRETT ESOPHAGUS; CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; DISEASE PROGRESSION; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; ESOPHAGUS; FEMALE; GENES, ERBB-2; GENES, MYC; GENES, P16; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; METAPLASIA; MIDDLE AGED; PRECANCEROUS CONDITIONS; TRANS-ACTIVATORS;

EID: 84856019095     PISSN: 00468177     EISSN: 15328392     Source Type: Journal    
DOI: 10.1016/j.humpath.2011.04.018     Document Type: Article

References (35)

1. L.M. Brown, S.S. Devesa, and W.H. Chow Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age J Natl Cancer Inst 100 2008 1184 1187
2. R.C. Haggitt Barrett's esophagus, dysplasia, and adenocarcinoma Hum Pathol 25 1994 982 993 (Pubitemid 24313642)
3. E.R. Fearon, and B. Vogelstein A genetic model for colorectal tumorigenesis Cell 61 1990 759 767
4. A. Bombonati, and D.C. Sgroi The molecular pathology of breast cancer progression J Pathol 223 2011 307 317
5. J.B. Koorstra, S.R. Hustinx, G.J. Offerhaus, and A. Maitra Pancreatic carcinogenesis Pancreatology 8 2008 110 125 (Pubitemid 351670364)
6. Y. Mitsuuchi, and J.R. Testa Cytogenetics and molecular genetics of lung cancer Am J Med Genet 115 2002 183 188 (Pubitemid 35265508)
7. C.C. Maley, P.C. Galipeau, X. Li, C.A. Sanchez, T.G. Paulson, and B.J. Reid Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus Cancer Res 64 2004 3414 3427 (Pubitemid 38657913)
8. B.J. Reid P53 and neoplastic progression in Barrett's esophagus Am J Gastroenterol 96 2001 1321 1323 (Pubitemid 32455052)
9. S. Rauser, R. Weis, and H. Braselmann Significance of HER2 low-level copy gain in Barrett's cancer: implications for fluorescence in situ hybridization testing in tissues Clin Cancer Res 13 2007 5115 5123 (Pubitemid 47502079)
10. C.C. Maley, P.C. Galipeau, and J.C. Finley Genetic clonal diversity predicts progression to esophageal adenocarcinoma Nat Genet 38 2006 468 473
11. S.M. Brankley, K.K. Wang, and A.R. Harwood The development of a fluorescence in situ hybridization assay for the detection of dysplasia and adenocarcinoma in Barrett's esophagus J Mol Diagn 8 2006 260 267 (Pubitemid 43811251)
12. E.G. Barr Fritcher, S.M. Brankley, and B.R. Kipp A comparison of conventional cytology, DNA ploidy analysis, and fluorescence in situ hybridization for the detection of dysplasia and adenocarcinoma in patients with Barrett's esophagus Hum Pathol 39 2008 1128 1135
13. A.J. Cameron, and H.A. Carpenter Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study Am J Gastroenterol 92 1997 586 591 (Pubitemid 27184369)
14. B.R. Kipp, H.L. Tyner, and M.B. Campion Chromosomal alterations detected by fluorescence in situ hybridization in urothelial carcinoma and rarer histologic variants of bladder cancer Am J Clin Pathol 130 2008 552 559
15. A.M. Rygiel, F. Milano, and F.J. Ten Kate Gains and amplifications of c-myc, EGFR, and 20.q13 loci in the no dysplasia-dysplasia-adenocarcinoma sequence of Barrett's esophagus Cancer Epidemiol Biomarkers Prev 17 2008 1380 1385
16. B.J. Reid, L.J. Prevo, and P.C. Galipeau Predictors of progression in Barrett's esophagus II: baseline 17p (p53) loss of heterozygosity identifies a patient subset at increased risk for neoplastic progression Am J Gastroenterol 96 2001 2839 2848 (Pubitemid 32959522)
17. J.A. Jankowski, N.A. Wright, and S.J. Meltzer Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus Am J Pathol 154 1999 965 973 (Pubitemid 29169728)
18. D.J. Wong, T.G. Paulson, and L.J. Prevo p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium Cancer Res 61 2001 8284 8289 (Pubitemid 33091623)
19. Y.S. Bian, M.C. Osterheld, C. Fontolliet, F.T. Bosman, and J. Benhattar p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus Gastroenterology 122 2002 1113 1121 (Pubitemid 34267292)
20. C. Bernstein, H. Bernstein, C.M. Payne, K. Dvorak, and H. Garewal Field defects in progression to gastrointestinal tract cancers Cancer Lett 260 2008 1 10
21. P.C. Galipeau, L.J. Prevo, C.A. Sanchez, G.M. Longton, and B.J. Reid Clonal expansion and loss of heterozygosity at chromosomes 9p and 17p in premalignant esophageal (Barrett's) tissue J Natl Cancer Inst 91 1999 2087 2095 (Pubitemid 30019569)
22. P.C. Galipeau, D.S. Cowan, and C.A. Sanchez 17p (p53) allelic losses, 4N (G2/tetraploid) populations, and progression to aneuploidy in Barrett's esophagu Proc Natl Acad Sci U S A 9 1996 7081 7084 (Pubitemid 26243505)
23. K.K. Krishnadath, H.W. Tilanus, and M. van Blankenstein Accumulation of genetic abnormalities during neoplastic progression in Barrett's esophagus Cancer Res 55 1995 1971 1976
24. D. Chatelain, and J.F. Fléjou High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins Virchows Archiv 442 2003 18 24 (Pubitemid 36221344)
25. M.T. Barrett, C.A. Sanchez, P.C. Galipeau, K. Neshat, M. Emond, and B.J. Reid Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barrett's esophagus Oncogene 13 1996 1867 1873 (Pubitemid 26397445)
26. D.J. Wong, M.T. Barrett, R. Stoger, M.J. Emond, and B.J. Reid p16INK4a promoter is hypermethylated at a high frequency in esophageal adenocarcinomas Cancer Res 57 1997 2619 2622 (Pubitemid 27283770)
27. B. Klump, C.J. Hsieh, K. Holzmann, M. Gregor, and R. Porschen Hypermethylation of the CDKN2/p16 promoter during neoplastic progression in Barrett's esophagus Gastroenterology 115 1998 1381 1386 (Pubitemid 28545988)
28. T.G. Paulson, P.C. Galipeau, and L. Xu p16 mutation spectrum in the premalignant condition Barrett's esophagus PLoS One 3 2008 e3809
29. H. Rajagopalan, and C. Lengauer Aneuploidy and cancer Nature 432 2004 338 341 (Pubitemid 39551662)
30. A. Walch, K. Specht, and K. Bink Her-2/neu gene amplification, elevated mRNA expression, and protein overexpression in the metaplasia-dysplasia- adenocarcinoma sequence of Barrett's esophagus Lab Invest 81 2001 791 801 (Pubitemid 32553401)
31. C.T. Miller, J.R. Moy, and L. Lin Gene amplification in esophageal adenocarcinomas and Barrett's with high-grade dysplasia Clin Cancer Res 9 2003 4819 4825 (Pubitemid 37323285)
32. H. Geddert, M. Zeriouh, M. Wolter, J.W. Heise, H.E. Gabbert, and M. Sarbia Gene amplification and protein overexpression of c-erb-b2 in Barrett carcinoma and its precursor lesions Am J Clin Pathol 118 2002 60 66 (Pubitemid 34734253)
33. J.F. Flejou, F. Paraf, and F. Muzeau Expression of c-erbB-2 oncogene product in Barrett's adenocarcinoma: pathological and prognostic correlations J Clin Pathol 47 1994 23 26 (Pubitemid 24057743)
34. T.P. Brien, R.D. Odze, C.E. Sheehan, B.J. McKenna, and J.S. Ross HER-2/neu gene amplification by FISH predicts poor survival in Barrett's esophagus-associated adenocarcinoma Hum Pathol 31 2000 35 39 (Pubitemid 30054384)
35. J.D. Croxtall, and K. McKeage Trastuzumab: in HER2-positive metastatic gastric cancer Drugs 70 2010 2259 2267